Oxyphenbutazone ameliorates carfilzomib induced cardiotoxicity in rats via inhibition of oxidative free radical burst and NF-κB/IκB-α pathway

• Päätekijät: Faisal Imam (Tekijä), Muhammad Afzal (Tekijä), Nehmat Ghaboura (Tekijä), Khalid Saad Alharbi (Tekijä), Imran Kazmi (Tekijä), Samiyah Alshehri (Tekijä), Sana Saeed Alqarni (Tekijä), Emine Guven (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2024-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Carfilzomib (CFZ), a chemotherapeutic agent used for multiple myeloma treatments reported to cause high incidence of cardiac events either new onset and/or exacerbate formerly diagnosed heart failure with ventricular and myocardial dysfunction.Purpose: Current research designed to explore and examin...